NTRA

Natera, Inc.

Services-Medical Laboratories · SIC 8071CIK 1604821Held by 14 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$2.31B

Net Income FY2025

$(0.21B)

EPS (Basic, as reported)

$-1.52

Net Margin FY2025

-9.0%

ROE FY2025

-12.2%

Total Equity

$1.71B

Shares Out

144M

Business description

Natera, Inc. — Services-Medical Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 213 → 2,306 +30.3% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue2132102583023916258201,0831,6972,306

Cost of revenue(134)(136)(158)———————

Research & development(42)(50)(51)(51)(100)(264)(316)(321)(404)(624)

Selling, general & administrative(136)(155)(155)(206)(304)(511)(589)(618)(841)(1,177)

Total operating expenses(314)(345)(372)(419)(607)(1,094)(1,361)(1,529)(1,919)(2,616)

Operating income(96)(134)(115)(116)(216)(468)(541)(446)(222)(310)

Interest expense(1)(4)(10)(11)(15)(8)(9)(13)(11)(4)

Other income (expense), net——————————

Pre-tax income(96)(136)(128)(123)(230)(471)(547)(435)(190)(268)

Income tax expense000(2)0(1)(1)0(1)(60)

Net income(96)(136)(128)(125)(230)(472)(548)(435)(190)(208)

EPS — basic($1.86)($2.56)($2.22)($1.79)($2.84)($5.21)($5.57)($3.78)($1.53)($1.52)

EPS — diluted($1.86)($2.56)($2.22)($1.79)($2.84)($5.21)($5.57)($3.78)($1.53)($1.52)

Shares outstanding — basic (M)52535870819198115125137

Shares outstanding — diluted (M)52545870819198115125137

Showing the latest 10 of 13 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.